Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce

JAMA

Volumn 290, Issue 18, 2003, Pages 2443-2454

  Stewart, Walter F ^a,b   Ricci, Judith A ^a   Chee, Elsbeth ^a   Morganstein, David ^c   Lipton, Richard ^d  

^a AdvancePCS Ctr for Work and Health   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

^c WESTAT   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTHRITIS; ARTICLE; BACKACHE; COST; DISABILITY; FEMALE; HEADACHE; HEALTH SURVEY; HUMAN; JOB PERFORMANCE; MALE; MUSCULOSKELETAL DISEASE; PAIN; PRIORITY JOURNAL; PRODUCTIVITY; UNITED STATES;

EID: 0242410368     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.18.2443     Document Type: Article

References (53)

1. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American Migraine Study. Cephalalgia. 1996;16:231-238.
2. Michel P, Dartigues JF, Londoulsi A, Henry P. Loss of productivity and quality of life in migraine sufferers among French workers: results from the GAZEL cohort. Headache. 1997;37:71-78.
3. Von Korff M, Stewart WF, Simon D, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology. 1998;50:1741-1745.
4. Dasbach EJ, Carides GW, Gerth WC, Santanello NC, Pigeon JG, Kramer MS. Work and productivity loss in the rizatriptan multiple attack study. Cephalalgia. 2000; 20:830-834.
5. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159: 813-818.
6. Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics. 2001;19:197-206.
7. Schulman EA, Cady RK, Henry D, et al. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind placebo-controlled clinical trial. Mayo Clin Proc. 2000; 75:782-789.
8. McCunney RJ. Health and productivity: a role for occupational health professionals. J Occup Environ Med. 2001;43:30-35
9. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the national health interview survey. Headache. 1993;33:29-35.
10. Stang P, Cady R, Batenhorst A, Hoffman L. Workplace productivity: a review of the impact of migraine and its treatment. Pharmacoeconomics. 2001; 19:231-244.
11. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health. 1992;46:443-446.
12. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA. 1998; 279:381-383.
13. Hildebrandt VH. Back pain in the working population: prevalence rates in Dutch trades and professions. Ergonomics. 1995;38:1283-1298.
14. Dartigues JF, Michel P, Lindoulsi A, Dubroca B, Henry P. Comparative view of the socioeconomic impact of migraine versus low back pain. Cephalalgia. 1998;18(suppl 21):26-29.
15. Rizzo JA, Abbott TA III, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care. 1998;36:1471-1488.
16. Guo HR, Tanaka S, Halperin WE, Cameron LL. Back pain prevalence in US industry and estimates of lost workdays. Am J Public Health. 1999;89:1029-1035.
17. Cole DC, Ibrahim SA, Shannon HS, Scott F, Eyles J. Work correlates of back problems and activity restriction due to musculoskeletal disorders in the Canadian national population health survey (NPHS) 1994-5 data. Occup Environ Med. 2001;58:728-734.
18. Fautrel B, Guillemin F. Cost of illness studies in rheumatic disease. Curr Opin Rheumatol. 2002;14: 121-126.
19. Yelin E. Arthritis: the cumulative impact of a common chronic condition. Arthritis Rheum. 1992;35: 489-497.
20. Greenberg PE, Finkelstein SN, Berndt ER. Calculating the workplace cost of chronic disease. Business Health. 1995;13:27-30.
21. Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions: National Arthritis Data Work Groups. Arthritis Rheum. 1995;38:1351-1362.
22. Coyte PC, Asche CV, Croxford R, Chan B. The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res. 1998;11:315-325.
23. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum. 2001;44:528-534.
24. Lee P. The economic impact of musculoskeletal disorders. Qual Life Res. 1994;3(suppl 1):S85-S91.
25. Yelin EH. Musculoskeletal conditions and employment. Arthritis Care Res. 1995;8:311-317.
26. Cull RE, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econ. 1992;2:103-115.
27. Osterhaus JT, Guterman DL, Piachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 1992;2:67-76.
28. Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the work place. J Occup Environ Med 1997;39:320-327.
29. Lerner D, Reed JI, Massarotti E, Wester LM, Burke TA. The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis. J Clin Epidemiol. 2002;55:197-208.
30. Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. When antihistamines go to work. Business Health. 1999;17:49-50.
31. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6:373-378.
32. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990 J Clin Psychiatry. 1993;54:405-418.
33. Henke CJ, Levin TR, Henning JM, Potter LP. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000;95:788-792.
34. Kessler RC, Almeida DM, Berglund P, Stang P. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87:289-295.
35. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs from health conditions in the US: results from the American Productivity Audit. J Occup Environ Med. In press.
36. Ricci JA, Stewart WF, Leotta C, Chee E. A comparison of six phone interviews designed to measure health-related lost productive work time. Value Health. 2001;4:460.
37. Stewart WF, Ricci JA, Leotta C. Health-related lost productive time: Recall interval and bias in cost estimates. J Occup Environ Med. In press.
38. Karasek R, Gordon G, Pietrokovsky C, Frese M, Pieper C. Job Content Instrument: Questionnaire and User's Guide, Version 1.1. Los Angeles: University of Southern California; 1986.
39. Bureau of Labor Statistics, Bureau of the Census. Current Population Survey. Available at: http://www.bls.census.gov/cps/cpsmain.htm. Accessibility verified September 30, 2003.
40. Groves RM, Lyberg LE. An overview of non-response issues in telephone surveys. In: Groves RM, Biemer PB, Lyberg LE, et al, eds. Telephone Survey Methodology. London, England: John Wiley & Sons Ltd; 1988:208.
41. Clark RG, Steel DG. The effect of using household as a sampling unit. Int Stat Rev. 2002;70:289-314.
42. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA 2003;289:3135-3144.
43. Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. 1996;5:215-238.
44. US Office of Personal Management. Federal Civilian Workforce Statistics: Occupations of Federal White-Collar and Blue-Collar Workers, as of September 39, 1999. Available at: http://www.opm.gov/feddata/ocwcbc99.pdf. Accessibility verified September 30, 2003.
45. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
46. Gazmararian JA, Baker DW, Williams MV, et al. Health literacy among Medicare enrollees in a managed care organization. JAMA. 1999;281:545-551.
47. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. Health literacy: report of the Council on Scientific Affairs. JAMA. 1999;281:552-557.
48. Lipton RB, Hamelsky SW, Kolodner K, Steiner TJ, Stewart WF. Migraine, quality of life and depression: a population-based case-control study. Neurology. 2000;55:629-635.
49. Berger ML, Murray JF, Xu J, Pauly M. Alternative valuations of work loss and productivity. J Occup Environ Med. 2001;43:18-24.
50. Lipton RB, Diamond S, Diamond M, Reed M, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638-645.
51. Stewart W, Lipton R. Need for care and perceptions of MIDAS among headache sufferers. CNS Drugs. 2002;16(suppl 1):5-11.
52. Cady RC, Ryan R, Jhingran P, O'Quinn S, Pait DG. Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med. 1998;158:1013-1018.
53. Dasbach EJ, Carides GW, Gerth WC, et al. Work and productivity loss in the rizatriptan multiple attack study. Cephalalgia. 2000;20:830-834.